First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr SS Agarwal, Dr K K Aggarwal)
14th April 2016
Liquid Lung Biopsy
Analyzing tumor DNA in blood will offer targeted treatments best suited to a patient’s lung cancer.
Doctors at the Dana-Farber Cancer Institute in Boston have developed a DNA test, called a liquid biopsy that can detect mutations in two key genes found in lung tumors. 

The Dana-Farber/Brigham and Women's Cancer Center is now offering this analysis to all patients with non-small cell lung cancer (NSCLC) at the point of diagnosis or when the cancer comes back after treatment. The results are available in 3 days. The test involves taking a sample of blood and fishing for free-floating DNA released by dying cancer cells.
The findings by Adrian G. Sacher, MD and colleagues are published online April 7, 2016 in the journal JAMA Oncology.
The team focused on two key genes, called EGRF and KRAS, which are faulty in around a third of patients with NSCLC. Each patient also underwent a traditional tissue biopsy for comparison.
To Read More or Comment, Click Here
Top News
Practice Updates

Lifestyle (Obesity/Diabetes):  Avoiding sunlight as hazardous as smoking
Lifestyle (Obesity/Diabetes): Type 1 diabetes lowers life-expectancy
eMedi Humor
Medicolegal Corner
eMedi Quiz
A. Yes, fewer people are getting skin cancer. 
B. No, skin–cancer rates and deaths from the disease are on the upswing. 
C. No, skin cancer is on the rise, but fatalities are down. 
D. Skin–cancer rates have been stable over the past decade. 
E. Yes, but only among older women.
Photo Quiz
Ask the Specialist Videos
Lifestyle Updates
eMediNexus Specialty Weekly Newsletters
Second Opinion Required
Press Release
Why an early diagnosis of dengue is essential
New Delhi (April 13, 2016) – India is believed to be the Dengue capital of the world with the most recorded cases of the disease. The monsoon season further increases its incidence owing to the innumerable potholes where water gets collected. This stagnant water acts as ideal breeding grounds for the Aedes mosquitoes, the vector responsible for spreading the illness. According to a recent report, over 58 lakh Indians are diagnosed with Dengue each year, a figure 282 times greater than the officially recorded number of 20,000 annual cases.
To Read More or Comment, Click Here
Yoga for Health
Yoga-based exercise improves balance and mobility 

Yoga interventions resulted in small improvements in balance and medium improvements in physical....Read more
Lybrate Updates

Dr KK Aggarwal: A 30-year-old lady wanted to conceive immediately after a miscarriage, should she?

Education is the most powerful weapon which you can use to change the world. Nelson Mandela
IMA Updates
IMA TB Initiative 
IMA Starts Nodal center for adverse drug reactions

IMA PvPI Initiative has started a nodal center at IMA headquarters. All IMA members can now report adverse reactions to drugs, vaccines, medical devices, Blood products and herbal products at IMA PvPI helpline 9717776514, open Monday to Friday 9-5.30PM
IMA Polio Dates
  • April 11th: bOPV would be available in private market but it is not to be opened or used before 25th April.
  • April 25: IMA Polio Switch Day, when tOPV would be completely withdrawn and replaced by bOPV in both routine immunization and polio campaigns.
  • 9th May: IMA National Validation Day when India would be declared free of tOPV. 

IMA Satyagraha -

Dr Good Dr Bad And Make Sure
eIMA News Update
Digital IMA
The Indian Medical Association (IMA) presents a series of weekly webcasts for the benefit of the Indian medical profession, engaging you with the latest in advocacy efforts for doctors, through an interactive exclusive digital webcast partnership with eMediNexus.
Webcast Date: 14th April 2016
Topic: Preparedness on Vector Borne Diseases
Faculty: Dr Charan singh, Additional Director (Public Health Delhi), Dr Ramesh Kumar